Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
By Bertalan Meskó, MD PhD
Elizabeth Holmes has no idea how much damage she has done with Theranos. As I often wrote, for digital technologies to gain ground and become part of our everyday lives, we need not only technological solutions but a cultural paradigm shift. Holmes rolled a massive rock in front of it.
Similarly, Facebook’s data privacy practices do not increase people’s confidence in the company’s products. All the scandals that have surrounded the social network could backfire when Facebook wants to step into healthcare – and this is exactly what we wrote about in our latest article, Is There A Place For Facebook In Healthcare? In it, we looked at what Facebook currently does in medicine and evaluated whether those are viable ways to follow in the future.
Take care,
Berci
Bertalan Meskó, MD PhD
The Medical Futurist
***
YOUR COMMENTS ARE APPRECIATED.
Thank You
***
***
***
https://healthcarefinancials.files.wordpress.com/2007/10/foreword-mata.pdf
Share this:
Filed under: Ethics, Experts Invited, Industry Indignation Index, Information Technology, Interviews, Investing | Tagged: Berci, Bertalan Meskó, Elizabeth Holmes, HIT, IT, Theranos |
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 
Trial UPDATE
https://www.msn.com/en-us/news/other/theranos-investor-betsy-devos-was-misled-by-elizabeth-holmes-on-the-tech-and-financials-representative-testifies/ar-AAPZdYM?li=BBnb7Kz
Brian
LikeLike
MARTIN SHKREIL
Two months after being released from prison, notorious fraudster Martin Shkreli is back in the pharma business. Sort of.
Shkreli, 39, who was released from prison in May after serving just over four years for securities fraud, announced in a press release Monday a new venture called “Druglike”—a decentralized computing network for early-stage drug discovery projects that Shkreli claimed would “disrupt the economics of the drug business.”
In a press release, Shkreli said the company would “remove barriers to early-stage drug discovery, increase innovation and allow a broader group of contributors to share the rewards.”
“Underserved and underfunded communities, such as those focused on rare diseases or in developing markets, will also benefit from access to these tools,” added the former drug exec, who is best known for inflating the price of a life-saving medication by 5,000 percent.
Shkreli was banned from the pharmaceutical industry for life in January, after a federal court found him guilty of monopolistic behavior in hiking the price of the drug, Daraprim. He was also ordered to hand over $64.6 million of the profits he made in selling it.
ADAM
LikeLike
EH gets 11 years
Joe
LikeLike
NOT So SUNNY
Ramesh “Sunny” Balwani, Theranos’ former chief operating officer, was sentenced to nearly 13 years in prison. Balwani was found guilty of all charges in a trial earlier this year that charged him with defrauding the blood testing startup’s patients and investors.
Riva
LikeLiked by 1 person